^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NIB103

    i
    Other names: NIB103, TAK-103, NIB-103
    Associations
    News
    Trials
    Company:
    Noile-Immune Biotech
    Drug class:
    Mesothelin-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials